eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

ViiV Healthcare UK Ltd
Stockley Park West, Uxbridge, Middlesex,, UB11 1BT, UK
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 14/09/2010
PIL Ziagen 300 mg Film Coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/09/2010 and displayed until Current
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 28/06/2010 and displayed until 14/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
Updated on 18/01/2010 and displayed until 28/06/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 11/12/2009 and displayed until 18/01/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 19/06/2009 and displayed until 11/12/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 25/09/2008 and displayed until 19/06/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 24/06/2008 and displayed until 25/09/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 30/01/2008 and displayed until 24/06/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to appearance of the medicine
  • Change to Further Information section
  • Change to dosage and administration
  • Change to date of revision
Updated on 15/03/2007 and displayed until 30/01/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change due to harmonisation of patient information leaflet
  • Change to date of revision
Updated on 12/03/2007 and displayed until 15/03/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change due to harmonisation of patient information leaflet
Updated on 21/06/2006 and displayed until 12/03/2007
Reasons for adding or updating:
  • Change of manufacturer
Updated on 05/05/2005 and displayed until 21/06/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 08/07/2004 and displayed until 05/05/2005
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 20/02/2004 and displayed until 08/07/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 01/09/2003 and displayed until 20/02/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 22/03/2001 and displayed until 01/09/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  abacavir sulfate